# OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
Canonical URL: https://biopharmsignal.com/news/OSUR/orasure-highlights-significant-operational-progress-and-value-creation-initiatives-following-letter-from-altai-capital
Ticker: OSUR
Company: OraSure Technologies, Inc.
Source: OraSure Technologies, Inc.
Published: 2026-03-17 20:53 EST
Original Source URL: https://orasure.gcs-web.com
## Summary

Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026 Highlights Extensive Engagement with Altai Altai Has Rejected All Settlement Proposals and Is Singularly Focused on Securing Board Representation for Its Founder to

## Article Body
Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026 Highlights Extensive Engagement with Altai Altai Has Rejected All Settlement Proposals and Is Singularly Focused on Securing Board Representation for Its Founder to
## Recent Company News
- 2026-05-06 20:05 EST — [OraSure Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-first-quarter-2026-financial-results) — Source: OraSure Technologies, Inc.
- 2026-04-22 20:10 EST — [OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th](https://biopharmsignal.com/news/OSUR/orasure-to-announce-first-quarter-2026-financial-results-and-host-earnings-call-on-may-6th) — Source: OraSure Technologies, Inc.
- 2026-04-17 00:10 EST — [OraSure Technologies Appoints John D. Bertrand to its Board of Directors](https://biopharmsignal.com/news/OSUR/orasure-technologies-appoints-john-d-bertrand-to-its-board-of-directors) — Source: OraSure Technologies, Inc.
- 2026-03-17 20:53 EST — [OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital](https://biopharmsignal.com/news/OSUR/orasure-highlights-significant-operational-progress-and-value-creation-initiatives-following-letter-from-altai-capital) — Source: OraSure Technologies, Inc.
- 2026-02-25 21:05 EST — [OraSure Announces Fourth Quarter 2025 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-fourth-quarter-2025-financial-results) — Source: OraSure Technologies, Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)